無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

乳房病変位置特定法の世界市場:タイプ(ガイドワイヤー式、ラジオアイソトープ式、磁気トレーサー式)別 市場分析と予測 2018年〜2025年

Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report By Type (Wire Guided, Radioisotope Localization, Magnetic Tracer), By Region, And Segment Forecasts, 2018 - 2025

発行 Grand View Research, Inc. 商品コード 544769
出版日 ページ情報 英文 78 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.61円で換算しております。
Back to Top
乳房病変位置特定法の世界市場:タイプ(ガイドワイヤー式、ラジオアイソトープ式、磁気トレーサー式)別 市場分析と予測 2018年〜2025年 Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report By Type (Wire Guided, Radioisotope Localization, Magnetic Tracer), By Region, And Segment Forecasts, 2018 - 2025
出版日: 2018年11月09日 ページ情報: 英文 78 Pages
概要

世界の乳房病変位置特定法市場は、2018年から2025年にかけて13.3%のCAGRで推移し、2025年までに15億8,000万米ドル規模の市場に成長することが予測されています。乳癌診断、生検、検査などに対する医療費償還制度の拡充、女性の標的疾患罹患率の上昇とそれに伴う医療インフラの向上に対するニーズの高まりなどによって、当市場の成長が促進されています。

当レポートでは、世界の乳房病変位置特定法の世界市場を調査し、市場の概要、タイプ・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場機会、市場シェア、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

  • 市場のスナップショット

第3章 市場変数、動向、範囲

  • 市場区分と範囲
  • 市場規模と成長の見通し
  • 成長の見通しマッピング
  • SWOT分析(政治/法律/経済/技術)
  • ファイブフォース分析

第4章 乳房病変位置特定法市場の動向と分析:タイプ別

  • 市場動向の分析:タイプ別
  • ガイドワイヤー式
  • ラジオアイソトープ式
    • ROLL法
    • RSL法
    • その他
  • 磁気トレーサー式
  • その他

第5章 乳房病変位置特定法市場の動向と分析:地域別

  • 市場シェアの分析:地域別
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • 戦略の枠組み
  • 参入企業の分類
  • 企業プロファイル
    • Cook Medical
    • Sterylab
    • C.P Medical
    • C R Bard
    • Cianna Medical, Inc.
    • SOMATEX Medical Technologies GmbH
    • Argon Medical Devices, Inc.
図表

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 List of methods for breast lesion localization
  • TABLE 3 North America breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 4 North America radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 5 U.S. breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 6 U.S radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 7 Canada breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 8 Canada radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 9 Europe breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 10 Europe radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 11 U.K. breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 12 U.K. radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 13 Germany breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 14 Germany radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 15 Asia Pacific breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 16 Asia Pacific radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 17 Japan breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 18 Japan radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 19 China breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 20 China radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 21 India breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 22 India radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 23 Latin America breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 24 Latin America radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 25 Brazil breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 26 Brazil Breast radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 27 Mexico breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 28 Mexico Breast radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 29 MEA breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 30 MEA radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)
  • TABLE 31 South Africa breast lesion localization methods market estimates, by type, 2014 - 2025 (USD Million)
  • TABLE 32 South Africa radiosotope breast lesion localization methods market forecast, by type, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Value chain based sizing & forecasting
  • FIG. 4 QFD modeling for market share assessment
  • FIG. 5 Market summary
  • FIG. 6 Market trends & outlook
  • FIG. 7 Market segmentation & scope
  • FIG. 8 The global breast lesion localization methods market, 2014-2025 (USD Million)
  • FIG. 9 Market driver relevance analysis (Current & future impact)
  • FIG. 10 Percentage of all estimated new cancer cases in women 2017
  • FIG. 11 Percentage of all estimated cancer deaths in women 2017
  • FIG. 12 Market restrain relevance analysis (Current & future impact)
  • FIG. 13 Penetration & growth prospect mapping
  • FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 15 Porter's Five Forces Analysis
  • FIG. 16 Breast lesion localization methods market type outlook key takeaways
  • FIG. 17 Breast lesion localization market: Type movement analysis
  • FIG. 18 Global wire guided localization market, 2014 - 2025 (USD Million)
  • FIG. 19 Global radio isotope localization market, 2014 - 2025 (USD Million)
  • FIG. 20 Radio occult lesion localization market, 2014 - 2025 (USD Million)
  • FIG. 21 Global radioisotope seed localization (RSL) market, 2014 - 2025 (USD Million)
  • FIG. 22 Global others market, 2014 - 2025 (USD Million)
  • FIG. 23 Global magnetic tracer market, 2014 - 2025 (USD Million)
  • FIG. 24 Global other localization methods market, 2014 - 2025 (USD Million)
  • FIG. 25 Regional market place: Key takeaways
  • FIG. 26 Breast lesion localization methods market: Regional movement analysis
  • FIG. 27 North America breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 28 U.S. breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 29 Canada breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 30 Europe breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 31 U.K. breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 32 Germany breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 33 Asia Pacific breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 34 Japan breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 35 China breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 36 India breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 37 Latin America breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 38 Brazil breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 39 Mexico breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 40 MEA breast lesion localization methods market, 2014 - 2025 (USD Million)
  • FIG. 41 South Africa breast lesion localization methods methods market, 2014 - 2025 (USD Million)
  • FIG. 42 Strategy framework
  • FIG. 43 Participant categorization
目次
Product Code: GVR-1-68038-958-6

The global breast lesion localization methods market size is expected to reach USD 1.58 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to witness a CAGR of 13.3% during the forecast period. Growing number of government and non-government reimbursement policies for the breast cancer diagnostics, biopsy, examination, and other medical procedures are estimated to increase the adoption of breast lesion localization methods. Moreover, high demand for better healthcare infrastructure and facilities due to rising prevalence of the target disease among women is expected to fuel the market growth.

It is more prevalent in women above the age of 50 years. Although it is majorly occurring in women, the male population has one in eight chances of being diagnosed with the target cancer. According to the WHO, almost 6.5% of all cancer-related deaths worldwide are caused by breast cancer. Increasing awareness level about breast cancer screening is expected to further enhance the market growth. For instance, in U.S., the Centre of Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides free access to timely breast and cervical diagnostic and screening services to the needy patients.

These screening programs include high-quality mammogram diagnosis, which involves breast X-rays, biopsies (if required), and an analytical judgment. Key companies, such as C.R. Bard, Inc.; Cianna Medical, Inc.; and Cook Medical, Inc. focus on business expansion in developing regions in an attempt to increase their market share. They are also adopting several other strategies, such as M&A and product launch. For instance, in October 2018, Cianna Medical, Inc. signed a merger agreement with Merit Medical Systems, Inc., in which the latter will provide clinical support for R&D to Cianna Medical, Inc. for commercializing new technologies in the market.

Further key findings from the study suggest:

  • The global breast lesion localization methods market was valued at USD 580.7 million in 2017 and is expected to grow lucratively over the forecast period
  • Wire-guided localization segment held the largest market share of 35.9% in 2017 owing to the presence of wide range of products and high adoption of this technique among end-users
  • Radioisotope localization is expected to witness significant growth over the forecast period as it is an effective, safe, and widely used procedure for preoperative localization of non-palpable, suspicious breast lesions
  • North America led the market with revenue of USD 209.96 million in 2017. The presence of key manufacturers in U.S., established healthcare infrastructure, and high adoption of localization devices are the factors responsible for its largest share

Asia Pacific is expected to witness the fastest CAGR of 15.3% during the forecast period due to increasing demand for breast conserving surgery.

Table of Contents

Chapter 1: Methodology and Scope

  • 1.1 Information Procurement
    • 1.1.1 Purchased database:
    • 1.1.2 GVR's internal database
  • 1.2 Research Methodology
  • 1.3 Geographic scope & assumptions
  • 1.4 Region-wise market calculation
    • 1.4.1 Region-wise market: Base estimates
    • 1.4.2 Global market: CAGR calculation
  • 1.5 Region-based segment share calculation
  • 1.6 List of Secondary Sources

Chapter 2: Executive Summary

  • 2.1 Market Snapshot

Chapter 3: Market Variables, Trends, & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Size and Growth Prospects
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Rising prevalence of breast cancer among women
      • 3.2.1.2 Increasing awareness through cancer screening programs
      • 3.2.1.3 Technology Advancements
      • 3.2.1.4 Availability of various techniques
      • 3.2.1.5 Demand for minimally invasive and accurate procedures
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Risk associated with breast localization methods
      • 3.2.2.2 Presence of complicated regulatory framework
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Breast lesion localization - SWOT Analysis, by Factor (Political & legal, economic and technological)
  • 3.5 Industry Analysis - Porter's

Chapter 4: Breast Lesion Localization Methods Market: Type Estimates & Trend Analysis

  • 4.1 Breast Lesion Localization Method Market: Type Movement Analysis
  • 4.2 Wire Guided Localization
    • 4.2.1 Wire guided localization market, 2014 - 2025 (USD Million)
  • 4.3 Radioisotope localization
    • 4.3.1 Radioisotope localization market, 2014 - 2025 (USD Million)
    • 4.3.2 Radio guided occult lesion localization (ROLL)
      • 4.3.2.1 Radio occult lesion localization market, 2014 - 2025 (USD Million)
    • 4.3.3 Radioisotope seed localization (RSL)
      • 4.3.3.1 Radioisotope seed localization (RSL) market, 2014 - 2025 (USD Million)
    • 4.3.4 Others
      • 4.3.4.1 Others market, 2014 - 2025 (USD Million)
  • 4.4 Magnetic Tracer
    • 4.4.1 Magnetic Tracer market, 2014 - 2025 (USD Million)
  • 4.5 Others
    • 4.5.1 Other localization methods market, 2014 - 2025 (USD Million)

Chapter 5: Breast Lesion Localization Methods Market: Regional Estimates & Trend Analysis, by Type

  • 5.1 Breast Lesion Localization Methods Market Share by Region, 2017 & 2025
  • 5.2 North America
    • 5.2.1 North America breast lesion localization methods market, 2014 - 2025 (USD Million)
    • 5.2.2 U.S.
    • 5.2.3 U.S. breast lesion localization methods market, 2014 - 2025 (USD Million)
    • 5.2.4 Canada
    • 5.2.5 Canada breast lesion localization methods market, 2014 - 2025 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe breast lesion localization methods market, 2014 - 2025 (USD Million)
    • 5.3.2 U.K.
    • 5.3.3 U.K. breast lesion localization methods market, 2014 - 2025 (USD Million)
    • 5.3.4 Germany
    • 5.3.5 Germany breast lesion localization methods market, 2014 - 2025 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific breast lesion localization methods market, 2014 - 2025 (USD Million)
    • 5.4.2 Japan
    • 5.4.3 Japan breast lesion localization methods market, 2014 - 2025 (USD Million)
    • 5.4.4 China
    • 5.4.5 China breast lesion localization methods market, 2014 - 2025 (USD Million)
    • 5.4.6 India
    • 5.4.7 India breast lesion localization methods market, 2014 - 2025 (USD Million)
  • 5.5 Latin America
    • 5.5.1 Latin America breast lesion localization methods market, 2014 - 2025 (USD Million)
    • 5.5.2 Brazil
    • 5.5.3 Brazil breast lesion localization methods market, 2014 - 2025 (USD Million)
    • 5.5.4 Mexico
    • 5.5.5 Mexico breast lesion localization methods market, 2014 - 2025 (USD Million)
  • 5.6 MEA
    • 5.6.1 MEA breast lesion localization methods market, 2014 - 2025 (USD Million)
    • 5.6.2 South Africa
    • 5.6.3 South Africa breast lesion localization methods market, 2014 - 2025 (USD Million)

Chapter 6: Competitive Landscape

  • 6.1 Strategy Framework
  • 6.2 Market Participation Categorization
  • 6.3 Company Profiles
    • 6.3.1 Cook Medical
      • 6.3.1.1 Company overview
      • 6.3.1.2 Financial performance
      • 6.3.1.3 Product benchmarking
      • 6.3.1.4 Strategic initiatives
    • 6.3.2 Sterylab
      • 6.3.2.1 Company overview
      • 6.3.2.2 Financial performance
      • 6.3.2.3 Product benchmarking
    • 6.3.3 C.P Medical
      • 6.3.3.1 Company overview
      • 6.3.3.2 Financial performance
      • 6.3.3.3 Product benchmarking
      • 6.3.3.4 Strategic initiatives
    • 6.3.4 C R Bard
      • 6.3.4.1 Company overview
      • 6.3.4.2 Financial performance
      • 6.3.4.3 Product benchmarking
      • 6.3.4.4 Strategic initiatives
    • 6.3.5 Cianna Medical, Inc.
      • 6.3.5.1 Company overview
      • 6.3.5.2 Financial performance
      • 6.3.5.3 Product benchmarking
      • 6.3.5.4 Strategic initiatives
    • 6.3.6 SOMATEX Medical Technologies GmbH
      • 6.3.6.1 Company overview
      • 6.3.6.2 Financial performance
      • 6.3.6.3 Product benchmarking
      • 6.3.6.4 Strategic initiatives
    • 6.3.7 Argon Medical Devices, Inc.
      • 6.3.7.1 Company overview
      • 6.3.7.2 Financial performance
      • 6.3.7.3 Product benchmarking
      • 6.3.7.4 Strategic initiatives
Back to Top